Dec 16 CDC panel recommends Pfizer, Moderna vaccines over Johnson & Johnson shot due to blood clot risk By Lauran Neergaard, Mike Stobbe, Associated Press Thursday's recommendation came after government advisers reviewed new safety data about rare but potentially life-threatening blood clots linked to J&J's shot. Continue reading
Dec 14 Pfizer confirms COVID pill’s results, effectiveness against omicron By Matthew Perrone, Associated Press The company also confirmed Tuesday that the pill delivered on promising early results in reducing COVID-19 hospitalizations and deaths. Continue reading
Dec 09 FDA expands Pfizer COVID booster, opens extra dose to age 16 By Lauren Neergaard and Matthew Perrone, Associated Press The U.S. and many other nations already urge adults to get a booster to pump up their immunity months after initial vaccination. Continue reading
Dec 08 Pfizer says COVID booster offers protection against omicron variant By Lauran Neergaard, Associated Press Pfizer and its partner BioNTech said lab tests showed a booster dose increased by 25-fold the level of so-called neutralizing antibodies against omicron. Continue reading
Nov 19 FDA expands COVID boosters to all adults, final hurdle ahead By Lauren Neergaard and Matthew Perrone, Associated Press If the Centers for Disease Control and Prevention agrees, tens of millions more Americans could have three doses of protection ahead of the new year. Anyone who got the one-dose Johnson & Johnson vaccine can already get a booster. Continue reading
Nov 17 Watch 5:48 How the COVAX vaccine program is faring, and what challenges developing nations still face By William Brangham, Karina Cuevas The Biden administration is ramping up plans for vaccine manufacturing for the coming year. But developing nations have been struggling with delays and short supplies for months and will not meet their vaccination goals for this year. Drug maker Moderna… Continue watching
Nov 16 Pfizer asks U.S. regulators to approve promising COVID pill By Matthew Perrone, Associated Press Pfizer is submitting its experimental pill for COVID-19 for U.S. authorization, setting the stage for a likely launch of the promising therapy in coming weeks. Continue reading
Nov 09 FDA to consider COVID-19 booster shots from Pfizer for all adults By Lauran Neergaard, Associated Press Pfizer is asking U.S. regulators to allow boosters of its COVID-19 vaccine for anyone 18 or older. Older Americans and other groups particularly vulnerable to the virus have had access to a third dose of the Pfizer and BioNTech vaccine… Continue reading
Nov 05 Watch 4:45 News Wrap: Pfizer says its COVID-19 pill cuts hospitalization, death risk by 90% In our news wrap Friday, Pfizer announced strong results for a pill to treat COVID-19. Trials show it cuts infections and deaths by nearly 90 percent in high-risk adults. Three white men accused of murdering Ahmaud Arbery, a Black man,… Continue watching
Nov 05 Pfizer says COVID-19 pill cut hospital, death risk by 90 percent By Matthew Perrone, Associated Press Since the beginning of the pandemic last year, researchers worldwide have been racing to find a pill to treat COVID-19 that can be taken at home to ease symptoms, speed recovery and keep people out of the hospital. Continue reading